Robert A. Scott filed an initial statement of beneficial ownership with the SEC on October 28, 2026, disclosing his status as a newly reporting director of Arcutis Biotherapeutics, Inc. (NASDAQ:ARQT), with an event date of October 23, 2026.

Key Highlights

  • Reporting person: Robert A. Scott, identified in the filing as a Director of Arcutis Biotherapeutics, Inc.
  • Event date: The date of the event requiring the statement is listed as October 23, 2026.
  • No securities held: The filing states explicitly, "No securities are beneficially owned."
  • No derivative securities: Table II contains no entries for derivative securities such as options or warrants.
  • Signed by attorney-in-fact: The form was signed by Latha Vairavan as attorney-in-fact for Robert A. Scott on October 28, 2026.

Arcutis Biotherapeutics Adds Director Robert A. Scott With No Initial Holdings

According to the filing, Robert A. Scott submitted a Form 3 - Initial Statement of Beneficial Ownership of Securities - in connection with his role as a Director of Arcutis Biotherapeutics, Inc., traded on NASDAQ:ARQT. The issuer's address on record for Scott is listed as 3027 Townsgate Road, Suite 300, Westlake Village, California 91361.

The filing reports no beneficial ownership of any non-derivative or derivative securities. Both Table I, covering common and other non-derivative securities, and Table II, covering derivative securities such as puts, calls, warrants, options, and convertible securities, contain no entries. The filing includes the explicit remark: "No securities are beneficially owned."

The form was filed by one reporting person and was signed on October 28, 2026, by Latha Vairavan acting as attorney-in-fact for Robert A. Scott, pursuant to an attached power of attorney listed as Exhibit EX-24. The filing is not identified as an amendment, and no prior Form 3 filing date is referenced.

What Was Disclosed

Robert A. Scott filed an initial beneficial ownership statement as a new Director of Arcutis Biotherapeutics, Inc., disclosing no direct or indirect holdings of any securities, including no derivative positions, as of October 23, 2026.